Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

dr_james_shannon

Dr James Shannon joins Immodulon Therapeutics board of directors

July 29, 2015 Research and Development, Sales and Marketing Immodulon

Dr James Shannon has joined Immodulon as a non-executive director with immediate effect. Bringing with him 30 years’ of experience …
Appointment
UCB

Mixed Phase 3 results for Sanofi and UCB

July 29, 2015 Research and Development LixiLan, Sanofi, UCB, clinical trials, epratuzumab, insulin, insulin glargine, phase III

Two drugs that pharma companies are pinning hopes on for future success have had mixed outcomes in key late-stage clinical …
News
Novartis window

Novartis forms Mereo as UK biotech spin-off

July 29, 2015 Research and Development Mereo, Novartis, biotech, rare diseases

Novartis has formed a new UK biotech company by selling three investigational drugs in exchange for shares in the new …
News
AstraZeneca plaque

Cambridge collaboration to boost precision medicine research

July 29, 2015 Research and Development Brabaham Institute, Cambridge, R&D, collaboration

A new consortium has been launched to act as a ‘match-making’ service between pharma companies and R&D researchers to develop …
News
Scales of justice

Judge rules pharma has ‘ethical’ transparency obligation – reaction

July 29, 2015 Research and Development Ben Goldacre, Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, sense about science, transparency

Both sides of a bitterly contested legal battle over a major part of the industry’s transparency drive have reacted to …
News
Gavel

Judge backs HRA in transparency legal case

July 28, 2015 Research and Development EU Clinical Trial Regulation, Richmond Pharmacology, alltrials, clinical trial regulation, clinical trials, health research authority, sense about science, transparency

A judge has ruled that there are likely to be no legal grounds to block the Health Research Authority’s plans …
News
Regeneron building

Sanofi and Regeneron in immuno-oncology push

July 28, 2015 Manufacturing and Production, Research and Development Cancer, PD-1 inhibitors, Regeneron, Sanofi, collaboration, immuno-oncology, pd-1

Pharma giants Sanofi and Regeneron are extending the partnership that brought new heart drug Praluent to the market, with a …
News
Antibiotic resistance

Rising to meet the infectious disease challenge

July 27, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Antibiotics, R&D, antibiotic resistance, infectious disease

Antibiotic-resistant infections gather more headlines than most other infectious disease topics, and have typically been seen as a neglected area …
Feature
Vaccination

EMA backs GSK’s malaria vaccine for use in Africa

July 24, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CHMP, Committee for Medicinal Products for Human USE, EMA, European Medicines Agency, GSK, WHO, malaria, world health organization

GSK has taken a significant step forward toward being the first company to bring a malaria vaccine to market, after …
News
EMA

EMA in push for more paediatric drug trials

July 24, 2015 Medical Communications, Research and Development EMA, European Medicines Agency, clinical trials, drug development, paediatrics

The European Medicines Agency has relaxed some of its rules around the development of drugs in children, in order to …
News
alzheimers_brain

Lilly, Biogen and Roche debut Alzheimer’s disease drug results

July 22, 2015 Research and Development Alzheimer's, Alzheimer's disease, Biogen, Conference, Eli Lilly, Roche, lilly

Big pharma companies have posted mixed results in trials of several potential new treatments for Alzheimer’s disease. But the results, …
News
Opdivo

BMS halts Opdivo kidney cancer trial early

July 22, 2015 Research and Development BMS, Bristol-Myers Squibb, European Commission, Kidney cancer, opdivo, renal cell carcinoma

Bristol-Myers Squibb has stopped its Phase III study of its immunotherapy drug Opdivo in people with kidney cancer early after …
News
NHS sign

Cancer Drugs Fund assessment to be handed over to NICE

July 22, 2015 Medical Communications, Research and Development CDF, Cancer, Cancer Drugs Fund, NHS, NHS England, NHSE, NICE, cost effectiveness, cost-effectiveness

NICE will oversee the evaluation of Cancer Drugs Fund treatments in future, under new plans due for consultation by NHS …
News
rtorbett

New ABPI executive director appointed

July 21, 2015 Manufacturing and Production, Research and Development, Sales and Marketing ABPI, Richard Corbett

The UK pharma trade body the ABPI has appointed Richard Corbett as its new executive director of commercial. Corbett will …
Appointment
Malthouse_Freeman

Parliamentary launch for UK life sciences group

July 21, 2015 Manufacturing and Production, Research and Development All Party Parliamentary Group on Life Sciences, Kit Malthouse, george freeman, government, lobbying, parliament

A Parliamentary body has been created to highlight the contribution the life sciences sector makes to the economy, and boost …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026